🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
66.89
-1.71 (-2.49%)
At close: Nov 20, 2026, 4:00 PM EST
67.48
+0.59 (0.89%)
After-hours: Nov 20, 2026, 7:30 PM EST

Globus Medical Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Globus Medical stock has a consensus rating of "Buy" and an average price target of $93.43. The average 1-year stock price forecast is 39.68% higher than the current stock price, while the lowest is $75 (+12.12%) and the highest is $110 (+64.45%).

Price Target: $93.43 (+39.68%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$75$93.43$95$110
Change+12.12%+39.68%+42.02%+64.45%

Analyst Ratings

The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy677776
Buy333334
Hold455545
Sell000000
Strong Sell000000
Total131515151415

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 7, 2026
Truist Financial
Truist Financial
Buy
Reiterates
$100 → $90
BuyReiterates$100 → $90+34.55%Nov 6, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$100
BuyReiterates$100+49.50%Nov 6, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$99 → $100
BuyReiterates$99 → $100+49.50%Nov 6, 2026
RBC Capital
RBC Capital
Buy
Reiterates
$85
BuyReiterates$85+27.07%Nov 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.11B
from 2.94B
Increased by 5.77%
Revenue Next Year
3.28B
from 3.11B
Increased by 5.50%
EPS This Year
4.98
from 3.98
Increased by 25.12%
EPS Next Year
5.34
from 4.98
Increased by 7.17%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
958.10M1.02B1.57B2.52B2.94B3.11B
Revenue Growth
21.43%6.76%53.35%60.62%16.65%5.77%
Gross Profit
718.88M760.01M1.09B1.70B2.00B2.16B
Gross Margin
75.03%74.30%69.62%67.46%68.07%69.60%
Operating Income
194.86M237.15M273.51M441.03M600.27M782.94M
Net Income
149.19M190.17M122.87M102.98M537.87M567.79M
EPS
----3.984.98
EPS Growth
----30.92%25.12%
Forward PE
33.4832.7420.7625.5421.5913.43
Free Cash Flow
----588.77M622.50M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.2B
Avg3.1B
Low3.1B

Revenue Growth

Revenue Growth202620272028
High
9.6%
Avg
5.8%
Low
5.1%

EPS Forecast

EPS202620272028
High5.05
Avg4.98
Low4.92

EPS Growth

EPS Growth202620272028
High
26.9%
Avg
25.1%
Low
23.6%